BNP Paribas Asset Management
IRON icon

BNP Paribas Asset Management’s Disc Medicine IRON Stock Holding History

BNP Paribas Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Sell
38,262
-1,648
-4% -$113K ﹤0.01% 1047
2026
Q1 		$2.55M Sell
39,910
-293
-0.7% -$20.3K ﹤0.01% 1024
2025
Q4 		$3.19M Buy
40,203
+39,990
+18,775% +$3.38M ﹤0.01% 951
2025
Q3 		$14K Buy
213
+11
+5% +$654 ﹤0.01% 1523
2025
Q2 		$11K Buy
+202
New +$9.49K ﹤0.01% 1736

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BNP Paribas Asset Management's IRON Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Disc Medicine (IRON) stake by 4.1% in Q2 2026, selling an estimated $113K and leaving 38,262 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

BNP Paribas Asset Management first reported a position in IRON in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.19M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • BNP Paribas Asset Management held 38,262 shares of Disc Medicine worth $2.8M as of Q2 2026.
  • BNP Paribas Asset Management sold 1,648 Disc Medicine shares in Q2 2026, an estimated $113K.
  • Disc Medicine made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1047 holding.
  • BNP Paribas Asset Management first reported a position in Disc Medicine in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Disc Medicine position peaked at $3.19M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.